JPWO2021151004A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021151004A5 JPWO2021151004A5 JP2022542394A JP2022542394A JPWO2021151004A5 JP WO2021151004 A5 JPWO2021151004 A5 JP WO2021151004A5 JP 2022542394 A JP2022542394 A JP 2022542394A JP 2022542394 A JP2022542394 A JP 2022542394A JP WO2021151004 A5 JPWO2021151004 A5 JP WO2021151004A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- disease
- viral vector
- factor
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062964565P | 2020-01-22 | 2020-01-22 | |
| US62/964,565 | 2020-01-22 | ||
| PCT/US2021/014770 WO2021151004A1 (en) | 2020-01-22 | 2021-01-22 | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023511062A JP2023511062A (ja) | 2023-03-16 |
| JPWO2021151004A5 true JPWO2021151004A5 (https=) | 2024-01-16 |
| JP2023511062A5 JP2023511062A5 (https=) | 2024-01-16 |
Family
ID=76992653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542394A Pending JP2023511062A (ja) | 2020-01-22 | 2021-01-22 | 遺伝子療法ベクターの形質導入を増加又は増強するための及び免疫グロブリンを除去又は低減するための組成物及び方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20230241247A1 (https=) |
| EP (1) | EP4093436A4 (https=) |
| JP (1) | JP2023511062A (https=) |
| KR (1) | KR20220161268A (https=) |
| CN (1) | CN115135343A (https=) |
| AU (1) | AU2021211730A1 (https=) |
| BR (1) | BR112022014264A2 (https=) |
| CA (1) | CA3165025A1 (https=) |
| CL (1) | CL2022001984A1 (https=) |
| CO (1) | CO2022011195A2 (https=) |
| IL (2) | IL325936A (https=) |
| MX (1) | MX2022009065A (https=) |
| PE (1) | PE20221780A1 (https=) |
| PH (1) | PH12022551843A1 (https=) |
| WO (1) | WO2021151004A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113660938A (zh) * | 2019-01-30 | 2021-11-16 | 国立研究开发法人国立精神·神经医疗研究中心 | 核酸递送复合物 |
| WO2023109928A1 (zh) * | 2021-12-16 | 2023-06-22 | 上海宝济药业有限公司 | 抗免疫球蛋白降解酶酶切的Fc变体 |
| JP2024547125A (ja) * | 2021-12-22 | 2024-12-26 | 上海宝済薬業股▲ふん▼有限公司 | 免疫グロブリン分解酵素ＩｄｅＥの変異体の用途 |
| CN117126270B (zh) * | 2023-10-25 | 2024-02-13 | 首都儿科研究所 | 一种2型人博卡病毒型别特异性抗体及其应用 |
| WO2025178891A1 (en) * | 2024-02-19 | 2025-08-28 | The Trustees Of Columbia University In The City Of New York | Targeting immunoglobulin for treating aging and metabolic diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200745163A (en) * | 2006-02-17 | 2007-12-16 | Syntonix Pharmaceuticals Inc | Peptides that block the binding of IgG to FcRn |
| US10336825B2 (en) * | 2014-04-30 | 2019-07-02 | Hanall Biopharma Co., Ltd. | Antibody binding to FcRn for treating autoimmune diseases |
| GB201502305D0 (en) * | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| US20230220069A1 (en) * | 2020-06-17 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of gene therapy patients |
-
2021
- 2021-01-21 IL IL325936A patent/IL325936A/en unknown
- 2021-01-22 AU AU2021211730A patent/AU2021211730A1/en active Pending
- 2021-01-22 JP JP2022542394A patent/JP2023511062A/ja active Pending
- 2021-01-22 IL IL294558A patent/IL294558B1/en unknown
- 2021-01-22 EP EP21743720.1A patent/EP4093436A4/en active Pending
- 2021-01-22 KR KR1020227028570A patent/KR20220161268A/ko active Pending
- 2021-01-22 PH PH1/2022/551843A patent/PH12022551843A1/en unknown
- 2021-01-22 WO PCT/US2021/014770 patent/WO2021151004A1/en not_active Ceased
- 2021-01-22 US US17/759,183 patent/US20230241247A1/en active Pending
- 2021-01-22 PE PE2022001463A patent/PE20221780A1/es unknown
- 2021-01-22 CA CA3165025A patent/CA3165025A1/en active Pending
- 2021-01-22 MX MX2022009065A patent/MX2022009065A/es unknown
- 2021-01-22 CN CN202180010462.XA patent/CN115135343A/zh active Pending
- 2021-01-22 BR BR112022014264A patent/BR112022014264A2/pt unknown
-
2022
- 2022-07-21 CL CL2022001984A patent/CL2022001984A1/es unknown
- 2022-08-09 CO CONC2022/0011195A patent/CO2022011195A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104520428B (zh) | 将基因转移到细胞、器官和组织的aav载体组合物和方法 | |
| US20260049333A1 (en) | Variant AAV and Compositions, Methods and Uses for Gene Transfer to Cells, Organs and Tissues | |
| JP2024073614A (ja) | プラスミドを用いないａａｖベクター産生細胞株 | |
| JP7801093B2 (ja) | 細胞トランスフェクション及び／又はｒＡＡＶベクター産生の改善のための増強剤 | |
| JP2015509711A5 (https=) | ||
| RU2766583C2 (ru) | Масштабируемые способы получения рекомбинантного вектора на основе аденоассоциированного вируса (aav) в системе бессывороточной суспензионной культуры клеток, подходящего для клинического применения | |
| JP2020530834A5 (https=) | ||
| JP2020528734A5 (https=) | ||
| CA3069880A1 (en) | Apheresis methods and uses | |
| RU2015144047A (ru) | Векторы, содержащие спейсерные/филлер полинуклеотидные последовательности, и способы их применения | |
| JPWO2021151004A5 (https=) | ||
| RU2021100780A (ru) | Композиции и способы для повышения или усиления трансдукции векторов для генной терапии и для удаления или снижения иммуноглобулинов | |
| EP4349365A1 (en) | Co-treatment for gene therapy | |
| US20260000670A1 (en) | Prevention or mitigation of adverse effects related to recombinant viral vectors | |
| WO2025264490A1 (en) | Dna promoters | |
| WO2025264565A1 (en) | Promoters | |
| JP2024520838A (ja) | アデノ随伴ウイルス産生を制御する方法 |